logo
Students will spend 25 YEARS on their phones if screen habits don't change, study finds

Students will spend 25 YEARS on their phones if screen habits don't change, study finds

Daily Mail​3 hours ago

Students will spend 25 years glued to their phones if they don't change their screen habits, a study has found.
The average school, college or university student spends five and a half hours on their phone per day, which could amount to 25 years of their lives.
And the four per cent who spend nine hours or more on their phone could see themselves wasting 41 years of their lives locked into a screen.
The research, which was conducted by Fluid Focus over the first five months of the year, highlights rates of smartphone usage, the negative impact it has on learning and attention span, and student's desire to reduce it.
Their figures are based on a waking day of 16 hours and 72 years of smartphone use from the age of 11 to 83.
To get their figures, they tracked the screen times of 1,346 secondary school pupils, 198 university students and 1,296 people at further education colleges.
App genres which dominated the screens were social media, messaging and streaming.
Screen time averages increased with age - from five hours and 12 minutes for secondary school students to six hours and 12 minutes for university students.
For many students, their phone was the first thing they check when they wake up and the last thing they look at before bed.
Worryingly, 68 per cent of students believe their academic performance is impacted by their phone use.
Despite this self-awareness, around 40 per cent admitted to constantly checking their phone while studying.
Checking your phone seems like a harmless habit, but another study found it can take 20 minutes to regain focus afterwards.
Dr Paul Redmond, who studies generational change, called the findings 'quite stark'.
He was director of student experience and enhancement at Liverpool University, one of 18 institutions involved in the research.
He added: 'I think what's powerful is how students feel that it's damaging their academic performance. That awareness that "I could do so much better if I manage this".'
Nearly half of students (47 per cent) said their sleep is disturbed because of late-night phone usage, a figure that rose to 66 per cent for those at university.
Dr Redmond said it was helpful to talk with young people about strategies to manage screen time.
He explained how one new technique they tried out was to put elastic bands around their phones so when they took them out to go on them 'they were made to stop and think about why'.
Lisa Humphries is associate principal at Chichester College Group where some of the 11,000 students across its seven constituent colleges participated.
She said: 'By the time we see them in college, they've had five, six, seven years of living inside their phone. The levels of social anxiety are crippling in the young people we're seeing, and it comes from that whole thing.
'Everyone's living in their bedroom on their phone, and they're not outside, and they're not socialising, communicating. They're not developing those skills to build relationships.'
The report's authors urge schools, colleges and universities to make digital wellbeing part of their curriculum and strategic plans.
They even encouraged them to reward students who display healthy digital behaviours.
Another suggestion was to cut university lectures from 60 or 90 minutes to blocks of 30 minutes in order to cater to the new generations short attention spans.
They added the single biggest change a student can make is leaving their phone outside the bedroom up to 45 minutes before they want to go to sleep.
The authors also called for ministers to treat technology overuse as a public health problem and want their to be a public health campaign targeted at Gen Z.
Glenn Stephenson, co-founder of Fluid Focus, said: 'This research is a mirror. It forces us, as a society, to confront an uncomfortable truth: we unknowingly handed powerful, addictive technologies to children during their most formative years — without fully understanding the risks in doing so.
'However, what was great to see, and what should give us all hope, is that students aren't oblivious to the impact — far from it. They're aware, reflective, and increasingly motivated to change.
'Many are already trying. They just need to be met with the right education, the right tools and the belief that change is possible.'
Another study found three quarters of Gen Zs admitted struggling to maintain concentration while interacting with someone and 39 per cent feel a strong urge to look at their device.
Social events (28 per cent), speaking with friends (18 per cent) and parents (17 per cent) are some of the scenarios where the younger generation stop paying attention. And 28 per cent said they are even switching off at work, affecting their productivity.
The study of 2,000 18 to 28-year-olds found that Gen Z will reach for their phone after just two minutes and 15 seconds of talking to someone.
The biggest temptations when chatting face-to-face with someone include checking messages (48 per cent), scrolling social media (44 per cent) and even opening YouTube (18 per cent).
Calls (32 per cent), WhatsApp messages (23 per cent) and social media mentions (14 per cent) are deemed hardest to ignore. The research, commissioned by AXA UK as part of the annual Mind Health Report, found 63 per cent admit they struggle with real-life interaction – and 77 per cent use their phone as a form of escape.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ministers urged to provide more graduate training slots for UK medical students
Ministers urged to provide more graduate training slots for UK medical students

Western Telegraph

timean hour ago

  • Western Telegraph

Ministers urged to provide more graduate training slots for UK medical students

Dr Peter Prinsley, a retired ENT (ear, nose and throat) specialist who was elected for Labour last year, said thousands of British medicine graduates were missing out on doing further training every year because of a lack of places combined with the pressures from international medical graduates in the NHS. The British Medical Association has said about 20,000 applicants will miss out this year, if the number of available posts are the same. It added that according to the latest figures, there were 4.7 applications per post. The MP for Bury St Edmunds and Stowmarket said it had led to graduates moving abroad to do further study who sometimes do not return. He added there should be reserved spaces for UK graduates to be able to specialise and do further study. 33,108 Medical graduates applying for training posts British Medical Association Dr Prinsley told the PA news agency: 'The problem is that we've got a distorted competition ratio for the professional training slots. 'It should be a reasonable expectation that if you graduate from the UK medical school, you should have a reasonable chance of getting into higher professional training. 'There should be some competition. It shouldn't just be that you automatically progress with no effort, there should be a bit of competition, but the competition ratios have been hugely distorted by the requirement of the hospitals to provide junior doctors to staff their rotas.' It comes as Wes Streeting said UK medical graduates will be given priority for NHS jobs under the upcoming 10-year health plan. The Health Secretary told medical website on Thursday: 'I want to make sure that if you go through your medical training here in the UK, that you're able to work in the UK.' Mr Streeting added it was 'completely bonkers' to invest in training doctors but not ensure they can stay in the UK to work. The latest figures from the BMA showed there were 33,108 medical graduates applying for around 13,000 posts. This includes 12,305 UK graduates and 20,803 from overseas. The number of international medical graduates has doubled in two years, the figures show, while the UK ones have only risen by a third. The sharp rise in the number of international medical graduates has been down to the increased demand for doctors in the NHS to fill hospital vacancies. In 2023 more than two-thirds of new doctors (68%) joining the NHS were non-UK graduates, up from 47% in 2017. In a statement, the Department for Health and Social Care said the Government should not be 'over-reliant' on overseas recruitment. The problem has two solutions. We need less international medical graduates being recruited by the hospitals. We need to find an alternative way of staffing the rotas to run the hospitals Dr Peter Prinsley Doctors can go on to do further training after two foundation years in the NHS. If they apply and miss out on further study, they then move on to so-called foundation three status, where they can work as locums and apply for jobs within individual trusts. Some, however, opt to move abroad to work or study. The number doing another foundation year has risen in recent years. In its latest workforce report, the General Medical Council said the number of doctors not going into speciality training had grown and was a 'sizeable' part of the workforce. Dr Prinsley said he believes priority should be given to UK graduates and physician associates – who have less training – could be used to fill some of the roles taken up by overseas recruits. He said: 'The change that we need is not very difficult. We just need to make a situation in which we prioritise the UK training slots for the UK medical graduates. If we've got any slots we can't recruit to, then, of course, we extend it.' He added: 'The problem has two solutions. We need less international medical graduates being recruited by the hospitals. We need to find an alternative way of staffing the rotas to run the hospitals. 'There's a sort of golden mean, which would allow us to sort out the ratios of international medical graduates to British graduates, and also provide a meaningful role for these graduates as physician associates.' The British Medical Association will discuss the issue at its annual conference in Liverpool on Monday. In a motion put forward by members in the East Midlands, it asks the Government to 'significantly increase the number of training posts available for resident doctors'. It echoes a similar call by the Royal College of Physicians, who wrote in February 'UK graduates must be supported and enabled to enter postgraduate training schemes to continue their training in the NHS'. A Department of Health and Social Care spokesperson said: 'We are committed to building home-grown talent and ensuring UK medical graduates can find work in Britain – our 10 year health plan will tackle bottlenecks in the system. 'Internationally-trained staff remain an important part of the workforce but we should not be over reliant on overseas recruitment.'

NHS begins mass rollout of weight-loss jabs to patients in England
NHS begins mass rollout of weight-loss jabs to patients in England

The Guardian

timean hour ago

  • The Guardian

NHS begins mass rollout of weight-loss jabs to patients in England

Thousands of patients in England will be able to access weight-loss jabs via their GP from Monday for the first time. The mass rollout on the NHS means family doctors will be allowed to prescribe the drugs for the first time. About 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Eli Lilly, on the NHS over the next three years. The drug works by lowering blood sugar levels and slows down how quickly food is digested. From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people living with a range of other health problems. Patients previously needed to access the drugs through a special weight loss service. GP leaders said some family doctors had expressed concern about the additional workload, while pharmacy experts also said there could be pressure on supplies of the drug. In the first year of the programme, it will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity such as type 2 diabetes, high blood pressure, heart disease and obstructive sleep apnoea. Estimates suggest about 1.5 million people in the UK are already taking weight-loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Prof Kamila Hawthorne, the chair of the Royal College of GPs, said: 'While we recognise the potential benefits of weight-loss drugs, we know many GPs are concerned about the implications of the rollout of weight-loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, while weight-loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Olivier Picard, the chair of the National Pharmacy Association, said the demand for weight-loss jabs continued to rise sharply. 'As the NHS is now moving to implement National Institute for Health and Care Excellence guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly,' he said. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy.'

NHS changes weight loss jab rules as GPs prepare for Mounjaro demand
NHS changes weight loss jab rules as GPs prepare for Mounjaro demand

The Independent

timean hour ago

  • The Independent

NHS changes weight loss jab rules as GPs prepare for Mounjaro demand

A mass rollout of weight loss medication on the NHS in England is set to begin on Monday, as GPs are empowered for the first time to prescribe anti-obesity drug Mounjaro. The drug, also known as tirzepatide and manufactured by Lilly, is an antidiabetic medication that works by lowering blood sugar levels and slowing down the digestion of food. From Monday, GPs will be able to offer Mounjaro to severely obese individuals who also suffer from a range of other health complications, marking a crucial shift from the previous system where patients could only access such treatments through specialised weight loss services. This major initiative is expected to reach approximately 220,000 people across England over the next three years, targeting those identified as having the "greatest need" for intervention. But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout. And pharmacy experts also said there could be pressure on supplies of the drug. Who can get prescribed Mounjaro on the NHS? In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow. She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'. She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.' Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately. How do weight-loss jabs work? Explained 'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. ' Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice. 'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it. 'The biggest concern we have is that prescribing these medications alone misses the point. 'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up. 'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store